Home › Chronic Lymphocytic Leukemia
Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia na nagre-recruit sa U.S.
122 pag-aaral para sa Chronic Lymphocytic Leukemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA31 pag-aaral
- Columbus, OH29 pag-aaral
- Durham, NC28 pag-aaral
- Washington, DC22 pag-aaral
- Seattle, WA22 pag-aaral
- Rochester, MN20 pag-aaral
- New York City, NY20 pag-aaral
- Houston, TX18 pag-aaral
- Baldwin Park, CA18 pag-aaral
- Cincinnati, OH15 pag-aaral
- Milwaukee, WI15 pag-aaral
- Chicago, IL14 pag-aaral
- Nashville, TN13 pag-aaral
- Jacksonville, FL11 pag-aaral
- Atlanta, GA11 pag-aaral
- Philadelphia, PA11 pag-aaral
- Dallas, TX10 pag-aaral
- Portland, OR10 pag-aaral
- San Diego, CA10 pag-aaral
- Kansas City, MO10 pag-aaral
- Salt Lake City, UT10 pag-aaral
- Pittsburgh, PA10 pag-aaral
- Winston-Salem, NC9 pag-aaral
- Denver, CO9 pag-aaral
- Miami, FL9 pag-aaral
- Charlotte, NC9 pag-aaral
- Queens, NY8 pag-aaral
- Tampa, FL8 pag-aaral
- Minneapolis, MN8 pag-aaral
- Cleveland, OH8 pag-aaral
- Omaha, NE8 pag-aaral
- Los Angeles, CA8 pag-aaral
- Detroit, MI8 pag-aaral
- Des Moines, IA8 pag-aaral
- Fort Wayne, IN7 pag-aaral
- Newark, NJ7 pag-aaral
- St. Louis, MO7 pag-aaral
- Irvine, CA7 pag-aaral
- Cedar Rapids, IA7 pag-aaral
- Billings, MT7 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona15 pag-aaral
- Arkansas4 pag-aaral
- California34 pag-aaral
- Colorado17 pag-aaral
- Connecticut5 pag-aaral
- Delaware4 pag-aaral
- District of Columbia4 pag-aaral
- Florida34 pag-aaral
- Georgia16 pag-aaral
- Idaho4 pag-aaral
- Illinois17 pag-aaral
- Indiana12 pag-aaral
- Iowa10 pag-aaral
- Kansas7 pag-aaral
- Kentucky7 pag-aaral
- Louisiana7 pag-aaral
- Maine6 pag-aaral
- Maryland23 pag-aaral
- Massachusetts33 pag-aaral
- Michigan13 pag-aaral
- Minnesota30 pag-aaral
- Mississippi5 pag-aaral
- Missouri12 pag-aaral
- Montana7 pag-aaral
- Nebraska8 pag-aaral
- Nevada6 pag-aaral
- New Hampshire3 pag-aaral
- New Jersey15 pag-aaral
- New Mexico3 pag-aaral
- New York27 pag-aaral
- North Carolina35 pag-aaral
- Ohio44 pag-aaral
- Oklahoma4 pag-aaral
- Oregon16 pag-aaral
- Pennsylvania22 pag-aaral
- Rhode Island6 pag-aaral
- South Carolina5 pag-aaral
- South Dakota3 pag-aaral
- Tennessee16 pag-aaral
- Texas39 pag-aaral
- Utah10 pag-aaral
- Virginia12 pag-aaral
- Washington27 pag-aaral
- West Virginia3 pag-aaral
- Wisconsin19 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00923507A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05645107Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01087333Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04269902Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04844528A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06846671Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06967610ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07342478Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07428707Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07734038Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07582159A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT05947851HPC Offered for PRESERVE Expansion
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07145411A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05091424A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06588478A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07218341Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Nagre-recruitPhase 3
Edad 65 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07321652Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07520006A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07221500Family Study of Lymphoproliferative Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT00626496Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06839053A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06520098A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07508995Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT05724121Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.